VectorBuilder, a global leader in gene delivery technologies and CDMO solutions, will participate in the Association for ...

Ahead of its May 2, 2026 feature on The Alex McFarland Show, Transformed by His Promises: A 12-Week Devotional for Freedom from Life-Interfering Behaviors is being highlighted during Mental Health ...

MemorialCare Saddleback Medical Center has earned a Level 3 Geriatric Emergency Department Accreditation (GEDA) from the American College of Emergency Physicians, reaffirming its commitment to ...

Researchers addressed the need for long-term expression of CCR5-specific antibodies to establish protection from HIV using ...

In vitro data demonstratedself-complementary AAV9 (scAAV9) enabled ~30-fold higher MeCP2 protein expression compared to single-stranded AAV9 ...

Enrolment completed in Phase 2 part of head and neck cancer clinical trial (TG4050) – Topline data expected by the end of Q1 2028 as per plan ...

The College of Arts and Sciences' second Spotlight Symposium honors UB neurodevelopmental biologist Soo-Kyung Lee’s FOXG1 ...

Detailed price information for Geovax Labs Inc (GOVX-Q) from The Globe and Mail including charting and trades.

Enrolment completed in Phase 2 part of head and neck cancer clinical trial (TG4050) - Topline data expected by the end of Q1 2028 as per planPhase 1 data from TG4050 in head and neck cancer published ...

Detailed price information for Geovax Labs Inc (GOVX-Q) from The Globe and Mail including charting and trades.

Joining us today is Panna Sharma, Chief Executive Officer, President and Director of Lantern Pharma, who will guide us through the demonstration and discuss the broader implications of this technology ...